etomoxir has been researched along with glimepiride in 1 studies
Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (glimepiride) | Trials (glimepiride) | Recent Studies (post-2010) (glimepiride) |
---|---|---|---|---|---|
260 | 8 | 93 | 956 | 340 | 474 |
Protein | Taxonomy | etomoxir (IC50) | glimepiride (IC50) |
---|---|---|---|
ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | 6.39 | |
Bile salt export pump | Homo sapiens (human) | 10 | |
Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 0.85 | |
Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 6.86 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
1 other study(ies) available for etomoxir and glimepiride
Article | Year |
---|---|
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |